Study: Out-of-pocket EpiPen spending jumps 124% in 7 years

(By Mackenzie Bean for Becker’s Hospital Review)

The amount patients pay out-of-pocket for Mylan’s life-saving EpiPen device increased drastically since 2007, according to a study in JAMA Internal Medicine. Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or

Leave a Reply